Insider · CIK 0001734780
Stacy Markel
Files at NUVB (Nuvation Bio Inc.). First filing Jun 18, 2025, latest Jun 24, 2026.
In brief
Stacy Markel files SEC Form 4 as officer at NUVB (Nuvation Bio Inc.). Since Jun 18, 2025, Stacy Markel has reported 1 open-market buy worth $17k and 1 open-market sell worth $753k, the latest filed on Jun 24, 2026.
A track record needs three past buys with six months of prices behind them; Stacy Markel has 1, so none is measured yet.
The newest scored trade: sold $753k of NUVB on Jun 23, 2026, filed Jun 24, 2026, scored 37 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $753k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NUVB: Nuvation Bio Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Nuvation Bio Inc. | $753k 125,000 shares | -79% | +221% from low-37% from high | |
| 58Moderate | Nuvation Bio Inc. | $17k 10,000 shares | +51% | +8% from low-45% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | 125,000 0.04% of outstanding | $720k | Jun 23, 2026 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | MOption exercise Class A Common Stock10b5-1 | +90,380 | $1.87 | $169k | 122,971 | Jun 24, 2026 |
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | MOption exercise Class A Common Stock10b5-1 | +34,620 | $1.74 | $60k | 157,591 | Jun 24, 2026 |
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | SOpen-market sale Class A Common Stock10b5-1 | -125,000 | $6.03 | $753k | 32,591 | Jun 24, 2026 |
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -90,380 | $0.00 | $0 | 409,620 | Jun 24, 2026 |
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -34,620 | $0.00 | $0 | 220,190 | Jun 24, 2026 |
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +748,130 | $0.00 | $0 | 748,130 | Mar 3, 2026 |
| Jun 18, 2025 | NUVB Nuvation Bio Inc. | POpen-market purchase Class A Common Stock | +10,000 | $1.71 | $17k | 29,591 | Jun 18, 2025 |
Questions about Stacy Markel
Answered from the filings on this page, as of the latest one.
Is Stacy Markel buying or selling?
In the last 12 months Stacy Markel reported 0 open-market buys worth $0 and 1 open-market sell worth $753k on SEC Form 4; the latest was sold $753k of NUVB on Jun 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Stacy Markel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stacy Markel has 1.
Where does Stacy Markel file Form 4?
Stacy Markel has filed Form 4 at NUVB (Nuvation Bio Inc.) as CHIEF PEOPLE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.